Otolaryngology Doctors in Highlands Ranch, CO Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Courtney Lynn Cochran, PA-C Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 W County Line Rd Ste 330, Highlands Ranch, CO 80129 Phone: 303-795-5587

John Campana, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 Park Central Dr Ste 501, Highlands Ranch, CO 80129 Phone: 720-516-6325    Fax: 303-778-5621

Dr. Seth Allen Reiner, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 200 W County Line Rd, Suite 330, Highlands Ranch, CO 80129 Phone: 303-795-5587    Fax: 303-795-3404

Thomas Paul Gonsoulin, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 200 W County Line Rd, Suite 330, Highlands Ranch, CO 80129 Phone: 303-795-5587    Fax: 303-795-3404

News Archive

Researchers identify brain circuit that helps take major developmental step despite nutritional stress

When we go hungry, we have the ability to ignore the urge to eat such that we can carry out the task at hand. It has long been known that the brain is involved in such decisions.

Study paves the way for development of new therapeutic strategies to treat addiction

Drug addiction is a psychiatric disorder for which no pharmacological treatment with long-term efficacy currently exists. All addictive substances share the property of raising concentrations of the neurotransmitter dopamine within brain regions forming the neural reward circuit.

Spouses & Relatives Of Celiac Disease Patients At Risk For Autoimmune Diseases

Both spouses and first-degree relatives of patients with celiac disease are at increased risk of nonceliac autoimmune disease, according to a study in the July issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. This risk represents a mixture of genetic, environmental and ascertainment bias mechanisms.

Protox announces presentations on PRX302 for BPH at 2010 AUA Annual Meeting

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).

Europe: Data shows upward trend in chronic hepatitis B cases since 2008

In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.

Read more Medical News

› Verified 1 days ago